Clinical Trials Directory

Trials / Completed

CompletedNCT00926705

Dexmedetomidine Infusion in Hypospadias Surgery

An Intraoperative Infusion of Dexmedetomidine Reduces the Opioid Requirements for Pediatric Patients Undergoing Hypospadias Surgery

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
48 (actual)
Sponsor
University of Jordan · Academic / Other
Sex
Male
Age
1 Year – 12 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesize that giving Dexmedetomidine in combination with Fentanyl for pediatric patients undergoing hypospadias surgery, will reduce the fentanyl requirement for intraoperative and postoperative analgesia.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidine and FentanylDexmedetomidine in a dose of 1 ug/kg initial dose then continuous infusion of 0.7 ug/kg/hr . Combined with Fentanyl at a dose of 2 ug/kg initially plus boluses of fentanyl to keep the patient hemodynamically stable.
DRUGFentanylThis group received Fentanyl at a dose of 2 ug/kg initially, followed by boluses to keep the patient hemodynamically stable.

Timeline

Start date
2008-06-01
Completion
2009-01-01
First posted
2009-06-23
Last updated
2009-06-23

Locations

1 site across 1 country: Jordan

Source: ClinicalTrials.gov record NCT00926705. Inclusion in this directory is not an endorsement.

Dexmedetomidine Infusion in Hypospadias Surgery (NCT00926705) · Clinical Trials Directory